DeepMed Research

Ethicon, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1992-01-01

Employees: 10K

Market Cap: -

Website: http://www.ethicon.com

Clinical Trials

A Study of Two Types of Absorbable Surgical Sutures in the Suturing of Thyroid Surgery Incision

Not Applicable

Completed

Conditions: Sutures

Interventions: Device: Spiral PDS Plus
Device: Spiral MONOCRYL Plus
Device: PDS Plus
Device: MONOCRYL Plus
Device: VICRYL Plus

First Posted Date: 2019-01-03

Last Posted Date: 2022-04-05

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 501

Registration Number: NCT03792737

Locations: 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sicuan Province, China
🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, China
🇨🇳
The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China

and more 7 locations

NeuWave Microwave Ablation HCC China Study

Not Applicable

Completed

Conditions: Hepatocellular Carcinoma
Liver Tumor

Interventions: Device: Microwave ablation

First Posted Date: 2018-12-21

Last Posted Date: 2025-04-25

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 135

Registration Number: NCT03783871

Locations: 🇨🇳
The First Affiliated Hospital，Sun Yat-sen University, Guangzhou, Guangdong, China
🇨🇳
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
🇨🇳
Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

and more 1 locations

SURGICEL® Powder in Controlling Mild or Moderate Parenchymal or Soft Tissue Intraoperative Bleeding in Adult Subjects

Not Applicable

Completed

Conditions: Hemorrhage

Interventions: Device: SURGICEL Powder

First Posted Date: 2018-12-03

Last Posted Date: 2021-07-26

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 103

Registration Number: NCT03762200

Locations: 🇬🇧
Cambridge University Hospitals NHS Trust (Addenbrooke's Hospital), Cambridge, United Kingdom
🇬🇧
NHS Lothian (Western General Hospital), Edinburgh, Lothian, United Kingdom
🇧🇪
Universitair Ziekenhuis Gent, Gent, Belgium

and more 5 locations

Ablation Confirmation Study

Not Applicable

Terminated

Conditions: Cancer of the Liver
Liver Cancer
Neoplasms, Liver

Interventions: Device: Microwave Ablation

First Posted Date: 2018-11-27

Last Posted Date: 2024-01-05

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 46

Registration Number: NCT03753789

Locations: 🇺🇸
Loma Linda University Medical Center, Loma Linda, California, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
UCLA, Los Angeles, California, United States

and more 3 locations

NEUWAVE Flexible Probe Study #2

Not Applicable

Withdrawn

Conditions: Lung Cancer
Carcinoma, Non-Small Cell Lung
Non-Small Cell Lung Carcinoma
Non-Small Cell Lung Cancer
Cancer of the Lung
Neoplasms, Lung

Interventions: Device: Microwave ablation

First Posted Date: 2018-10-19

Last Posted Date: 2020-06-02

Lead Sponsor: Ethicon, Inc.

Registration Number: NCT03713099

Locations: 🇺🇸
FirstHealth Moore Regional Hospital, Pinehurst, North Carolina, United States
🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

and more 2 locations

NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung

Not Applicable

Terminated

Conditions: Cancer of Lung
Neoplasms, Lung
Cancer of the Lung
Carcinoma, Non-Small Cell Lung
Non-Small Cell Lung Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer

Interventions: Device: Microwave Ablation

First Posted Date: 2018-07-27

Last Posted Date: 2020-12-21

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 10

Registration Number: NCT03603652

Locations: 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸
New York Presbyterian-Weill Cornell Medicine, New York, New York, United States
🇺🇸
FirstHealth Moore Regional Hospital, Pinehurst, North Carolina, United States

and more 2 locations

Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea

Not Applicable

Completed

Conditions: Cancer, Hepatocellular
Carcinoma, Hepatocellular
Hepatocellular Carcinoma
Hepatocellular Cancer

Interventions: Device: Microwave ablation

First Posted Date: 2018-07-13

Last Posted Date: 2024-07-24

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 33

Registration Number: NCT03586050

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Prospective, Multicenter, Randomized Controlled Study to Evaluate the Effect of INTERCEED™

Phase 3

Terminated

Conditions: Subjects Scheduled to Undergo Laparoscopic Radical Resection of Rectal Carcinoma With Preventive Ileostomy

Interventions: Device: Placebo
Device: INTERCEED™

First Posted Date: 2018-03-12

Last Posted Date: 2022-08-10

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 175

Registration Number: NCT03462563

Locations: 🇨🇳
Shanghai Jiaotong University School of Medcine, Ruijin Hospital, Shanghai, Shanghai, China
🇨🇳
Changhai Hospital, Shanghai, China
🇨🇳
First affiliated hospital of zhengzhou university, Zhengzhou, Henan, China

and more 9 locations

The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study

Phase 3

Completed

Conditions: Controlling Mild to Moderate Bleeding During Surgery

Interventions: Biological: EVARREST® Fibrin Sealant Patch

First Posted Date: 2017-08-21

Last Posted Date: 2025-04-27

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 35

Registration Number: NCT03255174

Locations: 🇺🇸
University of Alabama Hospital, Birmingham, Alabama, United States
🇺🇸
icahn School of Medicine at Mt Sinai, New York, New York, United States
🇬🇧
Birmingham Chrildren's Hospital, Birmingham, United Kingdom

and more 2 locations

A Prospective, Multi-Center Evaluation of a Powered Vascular Stapler in Video-Assisted Thoracoscopic Lobectomies

Not Applicable

Completed

Conditions: Non-Small Cell Lung Cancer

Interventions: Device: Video-Assisted Thoracoscopic Lobectomy with powered vascular stapler

First Posted Date: 2017-02-17

Last Posted Date: 2019-01-30

Lead Sponsor: Ethicon, Inc.

Target Recruit Count: 50

Registration Number: NCT03056300

Locations: 🇨🇳
Beijing Cancer Hospital, Beijing City, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy